Anti-Ischemic Effect of Selectin Blocker Through Modulation of Tumor Necrosis Factor-α and Interleukin-10

Journal of Surgical Research

Volumn 138, Issue 2, 2007, Pages 275-283

  López Neblina, Fernando ^a   Toledo Pereyra, Luis H ^a,b  

^a Borgess Research Institute   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

IL 10; ischemia; molecular biology; selectins; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIMOSIAMOSE; INTERLEUKIN 10; SELECTIN ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; ISCHEMIA; LIVER FUNCTION TEST; LIVER ISCHEMIA; MALE; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALS; BIPHENYL COMPOUNDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERLEUKIN-10; LIVER; MALE; MANNOSIDES; MICE; MICE, INBRED C57BL; REPERFUSION INJURY; SELECTINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847678152     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.04.012     Document Type: Article

References (55)

1. Toledo-Pereyra L.H., Lopez-Neblina F., and Toledo A.H. Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann Transplant 9 (2004) 81
2. Martinez-Mier G., Toledo-Pereyra L.H., and Ward P.A. Adhesion molecules in liver ischemia/reperfusion. J Surg Res 94 (2000) 185
3. Toledo-Pereyra L.H., and Suzuki S. Cellular and biomolecular mechanisms of liver ischemia and reperfusion injury. Transplant Proc 26 (1994) 325
4. López-Neblina F., Paez-Rollis A., García Criado F.J., Misawa K., and Toledo-Pereyra L.H. El Oxido Nitrico exógeno previene el rodamiento y la adhesión leucocitaria en isquemia mesentérica en la rata. Cirujano General 17 (1995) 90
5. Kimoto T., Toledo-Pereyra L.H., López-Neblina F., and Paez A. The role of leukocyte-endothelial cell adhesion in liver transplantation: reperfusion injury and graft rejection. Transplantology 6 (1995) 20-31
6. Paez-Rollis A., Toledo-Pereyra L.H., López-Neblina F., García Criado F.J., and Misawa K. Endothelial cell adhesion molecules and kidney transplantation. Transplantology 6 (1995) 134-138
7. Palma-Vargas J.M., Toledo-Pereyra L.H., Harkema J.M., Kisala J., and Dean R.E. Blockade of beta-2 and beta-3 integrins protects the ischemic liver from severe inflammatory response. Surg Forum XLVIII (1997) 184
8. Suzuki S., Toledo-Pereyra L.H., Rodriguez F.J., and Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 55 (1993) 1265
9. Suzuki S., and Toledo-Pereyra L.H. Interleukin-1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 57 (1994) 253
10. Toledo-Pereyra L.H., Rivera-Chavez F.A., and Dean R. Hepatic ischemia and reperfusion: results from 21 years of research. Cirujano General 20 (1998) 273
11. Ramos-Kelly J.R., Toledo-Pereyra L.H., Jordan J., et al. Multiple selectin blockade with a small molecule inhibitor downregulates liver chemokine expression and neutrophil infiltration after hemorrhagic shock. J Trauma 49 (2000) 92-100
12. Martinez-Mier G., Toledo-Pereyra L.H., and Ward P.A. P-selectin and chemokine response after liver ischemia and reperfusion. J Am Coll Surg 191 (2000) 395
13. Rivera-Chavez F.A., Toledo-Pereyra L.H., Nora D.T., Bachulis B.L., Ilgenfritz F., and Dean R.E. P-selectin blockade is beneficial after uncontrolled hemorrhagic shock. J Trauma 45 (1998) 404
14. Kogan T.P., Dupre B., Bui H., et al. Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyloxy phenyl] hexane (TBC-1269). J Med Chem 41 (1998) 1099
15. Slee D.H., Romano S.J., Yu J., et al. Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity. J Med Chem 44 (2001) 2094
16. Kondrusik M., Swierzbinska R., Pancewicz S., Zajkowska J., Grygorczuk S., and Hermanowska-Szpakowicz T. Evaluation of proinflammatory cytokine (TNF-alpha, IL-1beta, IL-6, IFN-gamma) concentrations in serum and cerebrospinal fluid of patients with neuroborreliosis. Neurol Neurochir Pol 38 (2004) 265-270
17. Suzuki S., and Toledo-Pereyra L.H. Monoclonal antibody to intercellular adhesion molecule 1 as an effective protection for liver ischemia and reperfusion injury. Transplant Proc 25 (1993) 3325
18. Tilton R.G., and Berens K.L. Functional role for selectins in the pathogenesis of cerebral ischemia. Drug News Perspect 15 (2002) 351
19. Forlow S.B., and Ley K. Selectin-independent leukocyte rolling and adhesion in mice deficient in E-, P-, and L-selectin and ICAM-1. Am J Physiol Heart Circ Physiol 280 (2001) H634
20. Romano S.J., and Slee D.H. Targeting selectins for the treatment of respiratory diseases. Curr Opin Invest Drugs 2 (2001) 907
21. Nemoto T., Burne M.J., Daniels F., et al. Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Internat 60 (2001) 2205
22. Misawa K., Toledo-Pereyra L.H., Phillips M.L., Lopez-Neblina F., and Paez R.A. Role of Sialyl Lewis x in total hepatic ischemia and reperfusion. J Am Coll Surg 182 (1996) 251
23. Palma-Vargas J.M., Toledo-Pereyra L.H., Dean R.E., Harkema J.M., Dixon R.A.F., and Kogan T.P. Small molecule selectin inhibitor protects against liver inflammatory response after ischemia and reperfusion. J Am Coll Surg 185 (1997) 365
24. Toledo-Pereyra L.H., and Suzuki S. Neutrophils, cytokines, and adhesion molecules in hepatic ischemia and reperfusion injury. J Am Coll Surg 179 (1994) 758
25. Lopez-Neblina F., Toledo A.H., and Toledo-Pereyra L.H. Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg 18 (2005) 335
26. Colletti L.M., Burtch G.D., Remick D.G., et al. The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 49 (1990) 268
27. Sakr M.F., McClain C.J., Gavaler J.S., Zetti G.M., Starzl T.E., and Van Thiel D.H. FK 506 pre-treatment is associated with reduced levels of tumor necrosis factor and interleukin 6 following hepatic ischemia/reperfusion. J Hepatol 17 (1993) 301
28. Shito M., Wakabayashi G., Ueda M., et al. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 63 (1997) 143
29. Teoh N.C., and Farrell G.C. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 18 (2003) 891
30. Neuman M.G. Apoptosis in diseases of the liver. Crit Rev Clin Lab Sci 38 (2001) 109
31. Ding W.X., and Yin X.M. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med 8 (2004) 445
32. Lee N.K., and Lee S.Y. Modulation of life and death by the tumor necrosis factor receptor-associated factors (TRAFs). J Biochem Mol Biol 35 (2002) 61
33. Eichhorst S.T. Modulation of apoptosis as a target for liver disease. Expert Opin Ther Targets 9 (2005) 83
34. Girndt M., and Kohler H. Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk. Nephrol Dial Transplant 18 (2003) 1976
35. De Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209
36. De Waal Malefyt R., Haanen J., Spits H., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174 (1991) 915
37. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 15 (1995) 121
38. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 5 (1993) 263
39. Rennick D.M., and Fort M.M. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 278 (2000) G829
40. Powrie F., and Coffman R.L. Inhibition of cell-mediated immunity by IL4 and IL10. Res Immunol 144 (1993) 639
41. Herfarth H.H., Mohanty S.P., Rath H.C., Tonkonogy S., and Sartor R.B. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 39 (1996) 836
42. Herfarth H.H., Bocker U., Janardhanam R., and Sartor R.B. Subtherapeutic corticosteroids potentiate the ability of interleukin 10 to prevent chronic inflammation in rats. Gastroenterology 115 (1998) 856
43. Barbara G., Xing Z., Hogaboam C.M., Gauldie J., and Collins S.M. Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 46 (2000) 344
44. Rott O., Fleischer B., and Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24 (1994) 1434
45. Van Laethem J.L., Marchant A., Delvaux A., et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 108 (1995) 1917
46. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 19947;1:169.
47. Le Moine O., Louis H., Stordeur P., Collet J.M., Goldman M., and Deviere J. Role of reactive oxygen intermediates in interleukin 10 release after cold liver ischemia and reperfusion in mice. Gastroenterology 113 (1997) 1701
48. Lee Y.J., and Song Y.K. Cooperative interaction between interleukin 10 and galectin-3 against liver ischemia-reperfusion injury. Clin Cancer Res 8 (2002) 217
49. Jessup J.M., Samara R., Battle P., and Laguinge L.M. Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway. Clin Exp Metastasis 21 (2004) 709
50. Yoshidome H., Kato A., Edwards M.J., and Lentsch A.B. Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion. Am J Physiol 277 (1999) L919
51. Yoshidome H., Kato A., Edwards M.J., and Lentsch A.B. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology 30 (1999) 203
52. Gerard C., Bruyns C., Marchant A., et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177 (1993) 547
53. Persson S., Mikulowska A., Narula S., O'Garra A., and Holmdahl R. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 44 (1996) 607
54. Tanaka Y., Otsuka T., Hotokebuchi T., et al. Effect of IL-10 on collagen-induced arthritis in mice. Inflamm Res 45 (1996) 283
55. Toledo-Pereyra L.H., Lopez-Neblina F., Reuben J.S., Toledo A.H., and Ward P.A. Selectin inhibition modulates Akt/MAPK signaling and chemokine expression after liver ischemia-reperfusion. J Invest Surg 17 (2004) 303